Showing results (3151-3160 of 13,188) with videos related to

Sort By:
Pageof 1,319
Diabetes Care|July 26, 2023
Bidirectional Mendelian Randomization and Multiphenotype GWAS Show Causality and Shared Pathophysiology Between Depression and Type 2 DiabetesJared G Maina, Zhanna Balkhiyarova, Arie Nouwen, et al.
Diabetes Care|July 20, 2023
Long-term Effectiveness of the National Diabetes Quality Assessment Program in South KoreaJi Hye Huh, Serim Kwon, Gui Ok Kim, et al.
Diabetes Care|July 14, 2023
Evaluation of Insulin Pump Infusion Sites in Type 1 Diabetes: The DERMIS StudyAndrea Kalus, Michi M Shinohara, Ruikang Wang, et al.
Diabetes Care|July 10, 2023
Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 DiabetesRafael Simó, Josep Franch-Nadal, Bogdan Vlacho, et al.
Diabetes Care|July 18, 2023
Diet-Related Lipidomic Signatures and Changed Type 2 Diabetes Risk in a Randomized Controlled Feeding Study With Mediterranean Diet and Traditional Chinese or Transitional DietsYaogan Luo, Liang Sun, Qingqing Wu, et al.
Diabetes Care|July 20, 2023
A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of TreatmentsAlmut G Winterstein, Vera Ehrenstein, Jeffrey S Brown, et al.
Diabetes Care|August 11, 2023
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational StudyThomas S J Crabtree, Tomás P Griffin, Yew W Yap, et al.
Diabetes Care|August 9, 2023
Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 DiabetesAltayeb Ahmed, Hasnat Amin, Fotios Drenos, et al.
Diabetes Care|August 24, 2023
Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy With Continuous Glucose Monitoring in Adults With Type 1 Diabetes and Suboptimal Glycemic Control: A Single-Center, Randomized, Crossover StudyCharlotte K Boughton, Sara Hartnell, Rama Lakshman, et al.
Diabetes Care|August 22, 2023
Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell FunctionKevan C Herold, Stephen E Gitelman, Peter A Gottlieb, et al.
Pageof 1,319